Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort study-Reference-Cited by-同舟云学术

Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort study

Published:2015-10-20 Issue:11 Volume:13 Page:1980-1988
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Antun A.¹,Monahan P. E.²,Manco-Johnson M. J.³,Callaghan M. U.⁴^ORCID,Kanin M.⁵,Knoll C.⁶,Carpenter S. L.⁷,Davis J. A.⁸,Guerrera M. F.⁹,Kruse-Jarres R.¹⁰,Ragni M. V.¹¹,Witmer C.¹²,McCracken C. E.¹³,Kempton C. L.¹

Affiliation:

1. Department of Hematology and Medical Oncology; Emory University; Atlanta GA USA

2. Department of Pediatrics; University of North Carolina; Chapel Hill NC USA

3. Hemophilia and Thrombosis Center and Children's Hospital Colorado; University of Colorado; Aurora CO USA

4. Children's Hospital of Michigan; Detroit MI USA

5. Children's Hospital of Los Angeles; University of Southern California Keck School of Medicine; Los Angeles CA USA

6. Phoenix Children's Hospital; Phoenix AZ USA

7. Children's Mercy Hospital; Kansas City MO USA

8. Department of Pediatrics; University of Miami; Miami FL USA

9. Children's National Medical Center; Washington DC USA

10. Department of Medicine; Tulane University; New Orleans LA USA

11. Department of Medicine; University of Pittsburgh Medical Center and Hemophilia Center of Western Pennsylvania; Pittsburgh PA USA

12. Children's Hospital of Philadelphia; Philadelphia PA USA

13. Department of Pediatrics; Emory University; Atlanta GA USA

Funder

Novo Nordisk

National Institutes of Health

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13143/fullpdf

Reference10 articles.

1. The North American Immune Tolerance Registry: practices, outcomes, outcome predictors;DiMichele;Thromb Haemost,2002

2. The principal results of the International Immune Tolerance Study: a randomized dose comparison;Hay;Blood,2012

3. Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors;Coppola;J Thromb Haemost,2009

4. Adherence to medication;Osterberg;N Engl J Med,2005

5. F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity;Miller;Haemophilia,2012

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factor VIII antibody immune complexes modulate the humoral response to factor VIII in an epitope-dependent manner;Frontiers in Immunology;2023-08-31

2. Hemophilia a patients with inhibitors: Mechanistic insights and novel therapeutic implications;Frontiers in Immunology;2022-12-08

3. Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway;Frontiers in Immunology;2022-05-11

4. Emicizumab for All Pediatric Patients with Severe Hemophilia A;Hämostaseologie;2022-04

5. Factor-mimetic and rebalancing therapies in hemophilia A and B: the end of factor concentrates?;Hematology;2021-12-10